Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05585983
PHASE4

INfluenza VaccInation To Mitigate typE 1 Diabetes

Sponsor: Aarhus University Hospital

View on ClinicalTrials.gov

Summary

In a multicenter, prospective, randomized, controlled clinical trial to compare influenza vaccination and placebo in sustaining β cell function in early type 1 diabetes mellitus.

Official title: INfluenza VaccInation To Mitigate typE 1 Diabetes (INVITED Trial)

Key Details

Gender

All

Age Range

7 Years - 17 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2022-12-14

Completion Date

2027-05-01

Last Updated

2025-05-22

Healthy Volunteers

No

Interventions

BIOLOGICAL

Vaxigrip Tetra Sanofi Pasteur Europe

We will use 0.5 mL standard dose quadrivalent influenza vaccine containing 15 μg of hemagglutinin per strain consistent with WHO recommendations according to season.

Locations (10)

Aalborg University Hospital

Aalborg, Denmark

Aarhus University Hospital

Aarhus, Denmark

Steno Diabetes Center Copenhagen

Copenhagen, Denmark

Gødstrup Hospital

Herning, Denmark

Holbaek Sygehus

Holbæk, Denmark

Nykoebing F Sygehus

Nykøbing Falster, Denmark

Randers Regional Hospital

Randers, Denmark

Sjællands Universitetssygehus

Roskilde, Denmark

Slagelse Hospital

Slagelse, Denmark

Viborg Regional Hospital

Viborg, Denmark